Edelman, M. (2009, January 6). Phase III trials [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 30, 2022, from https://hstalks.com/bs/1116/.
Published on January 6, 2009
Archived on February 25, 2021
Dr. Edelman serves on Data Safety and Monitoring Boards for Astra Zeneca, Takeda, GSK and Seattle Genetics. He currently or has recently received research funding (to his institution) from Amgen, Regeneron, GSK. He has received compensation as a consultant for Flame, Kanaph, Regeneron, Windmil, and Proventus.